Home - Clinical Trials Arena
WEBPerimeter completes enrolment for AI-assisted breast imaging trial. The primary endpoint results from the trial are expected by the end of the year and will be used to support an FDA approval for the OCT B-Series device. More themes.
Gilead’s lenacapavir: HIV prospects strongest in long-acting …
WEBAug 25, 2021 · Gilead’s lenacapavir will find its strongest niche as a long-acting HIV combination treatment, experts said. Gilead announced a collaboration with Merck in March to study lenacapavir with islatravir, a nucleoside reverse transcriptase translocation inhibitor (NRTTI), which is also a new drug class in HIV.
FDA clears Revive Therapeutics’ Covid-19 trial of Bucillamine
WEBAug 3, 2020 · Revive Therapeutics has received approval from the US FDA to conduct a Phase III clinical trial of Bucillamine in patients with mild to moderate Covid-19.
SpikoGen: Cinnagen Covid-19 vaccine's Phase III results likely …
WEBSep 16, 2021 · SpikoGen, the protein subunit Covid-19 vaccine developed by Australia-based Vaxine, is likely to report Phase III results within two months.
Regulatory Roundup: CytoDyn's Cancer Asset Leronlimab Set to …
WEBDec 6, 2021 · Regulatory roundup: CytoDyn’s cancer asset leronlimab likely to advance after basket trial completion DermBiont in tinea versicolor is also reviewed by GlobalData’s Investigative News team.
Tesofensine Anti-Obesity Medication - Clinical Trials Arena
WEBDec 14, 2008 · Tesofensine is one of those set to enter trials as an anti-obesity medication. Some of the chemical signals (blue) that influence eating and affect the production and action of the body's fuels (green). The hypothalamus is the part of the brain that is responsible for controlling energy balance. The proportion of men …
Pfizer’s ritlecitinib meets primary efficacy goal in alopecia areata trial
WEBAug 5, 2021 · Pfizer has reported positive top-line data from the Phase IIb/III ALLEGRO trial of its drug, ritlecitinib, in alopecia areata patients.
Sinovac reports positive data from Phase I/II trials of CoronaVac
WEBJun 15, 2020 · China-based Sinovac Biotech has reported positive preliminary data from the Phase I/II clinical trials of its Covid-19 vaccine candidate, CoronaVac.
Alzheimer's trials: How does donanemab compare to lecanemab?
WEBJan 13, 2023 · Eli Lilly hopes donanemab will soon nab the second Alzheimer’s drug approval of 2023. Here’s a look at how donanemab stacks up to lecanemab.
Tango Therapeutics doses first patient with USP1 inhibitor trial
WEBJan 4, 2024 · Tango Therapeutics has dosed the first patient in the Phase I/II clinical trial investigating ubiquitin-specific protease 1 (USP1) inhibitor TNG348. The multi-centre, open-label study (NCT06065059) will evaluate the safety, tolerability, and preliminary antitumour activity of TNG348 alone, and in combination with AstraZeneca ’s PARP inhibitor Lynparza (olaparib) in patients with BRCA1/2 ...
- Some results have been removed